Literature DB >> 924518

Isolation and study of murine C3.

M B Pepys, A C Dash, A H Fielder, D D Mirjah.   

Abstract

C3 was isolated in purified form from fresh murine serum and plasma by precipitation as euglobulin followed by removal of other proteins on immunoadsorbent columns bearing antibodies raised against specifically C3 depleted serum. Recovery was 30--55% and the C3 was all in its native form. Functional activity was demonstrated by fixation of the C3 on EAC142gp cells and by interaction with lymphocyte C3 receptors. Mouse C3 in plasma and after isolation had a molecular weight of 240,000. Its cleavage by classical pathway and cobra factor induced C3 convertases and by trypsin yielded a major conversion product with molecular weight not less than 210,000, the electrophoretic mobility of which differed when it was generated from isolated C3 rather than in plasma.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 924518      PMCID: PMC1445393     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  9 in total

1.  MOUSE BETA-1C-GLOBULIN: PRODUCTION OF ANTISERUM AND CHARACTERIZATION IN THE COMPLEMENT REACTION.

Authors:  M R MARDINEY; H J MUELLER-EBERHARD
Journal:  J Immunol       Date:  1965-06       Impact factor: 5.422

2.  Role of complement in induction of the allergic response.

Authors:  M B Pepys
Journal:  Nat New Biol       Date:  1972-05-31

3.  Inhibition by C3 fragments of C3-dependent rosette formation and antigen-induced lymphocyte transformation.

Authors:  M B Pepys; A E Butterworth
Journal:  Clin Exp Immunol       Date:  1974-10       Impact factor: 4.330

4.  A new preparative method for isolation of human C3 with affinity chromatography.

Authors:  J L Molenaar; M Müller; K W Pondman
Journal:  J Immunol       Date:  1973-06       Impact factor: 5.422

Review 5.  Role of complement in the induction of immunological responses.

Authors:  M B Pepys
Journal:  Transplant Rev       Date:  1976

6.  Complement-mediated mixed aggregation of murine spleen cells.

Authors:  M B Pepys
Journal:  Nature       Date:  1974-05-03       Impact factor: 49.962

7.  Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.

Authors:  M Ballow; C G Cochrane
Journal:  J Immunol       Date:  1969-11       Impact factor: 5.422

8.  Interaction of human lymphocytes with fluid phase human C3b detected by immunofluorescence.

Authors:  S Simonian; J L Molenaar; W P Zeijlemaker; J T Knape; S Bakker; K W Pondman
Journal:  Eur J Immunol       Date:  1976-01       Impact factor: 5.532

9.  Changes produced in mouse plasma proteins by acute bacterial infections.

Authors:  C A WILLIAMS; C T WEMYSS
Journal:  J Exp Med       Date:  1961-09-01       Impact factor: 14.307

  9 in total
  12 in total

1.  Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself.

Authors:  Mark B Pepys; Philip N Hawkins; Melvyn C Kahan; Glenys A Tennent; J Ruth Gallimore; David Graham; Caroline A Sabin; Arturo Zychlinsky; Juana de Diego
Journal:  Circ Res       Date:  2005-10-27       Impact factor: 17.367

2.  Lymphocyte binding of fluid phase mouse C3b.

Authors:  M Papamichail; M B Pepys
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

3.  Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice.

Authors:  Gideon M Hirschfield; J Ruth Gallimore; Melvyn C Kahan; Winston L Hutchinson; Caroline A Sabin; G Martin Benson; Amar P Dhillon; Glenys A Tennent; Mark B Pepys
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-26       Impact factor: 11.205

4.  An interleukin-6-induced acute-phase response does not confer protection against lipopolysaccharide lethality.

Authors:  S E Bucklin; R Silverstein; D C Morrison
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

5.  Different allotypes of C3 degrade at different rates.

Authors:  P H Kay; S Natsuume-Sakai; J Hayakawa; R L Dawkins
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

6.  Isolation and characterization of the third component of rat complement.

Authors:  M R Daha; M Stuffers-Heiman; A Kijlstra; L A van Es
Journal:  Immunology       Date:  1979-01       Impact factor: 7.397

7.  Complement-independence of the acute-phase production of serum amyloijd P-component (SAP) in mice.

Authors:  M B Pepys; S L Rogers
Journal:  Br J Exp Pathol       Date:  1980-04

8.  Serum protein concentrations during Schistosoma mansoni infection in intact and T-cell deprived mice. I. The acute phase proteins, C3 and serum amyloid P-component (SAP).

Authors:  M B Pepys; M L Baltz; R Musallam; M J Doenhoff
Journal:  Immunology       Date:  1980-02       Impact factor: 7.397

9.  Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strains.

Authors:  M L Baltz; K Gomer; A J Davies; D J Evans; G G Klaus; M B Pepys
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

10.  Comparison of the role of complement in immunity to Schistosoma mansoni in rats and mice.

Authors:  D A Vignali; Q D Bickle; M G Taylor; G Tennent; M B Pepys
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.